Currently funded projects

Filter
Coronary angiography: Severely calcified coronary stenosis of the Right Coronary Artery before (A) and after (B) coronary Lithoplasty

Comparison of coronary Lithoplasty and Rotablation for the treatment of severely calcified coronary Stenoses – ROTA.shock-Study

Institution: Medizinische Klinik 1 – Kardiologie und Angiologie, Universitätsklinikum Gießen
Applicant : Dr. med. Florian Blachutzik
EKFS funding line: first application

Identifizierung von humanen Blut-Monozyten

Alteration of the monocyte repertoire after myocardial infarction – novel mechanistic insights and therapeutic avenues

Institution: Deutsches Herzzentrum München
Applicant: Priv. Doz. Dr. med. Hendrik Sager
EKFS funding line: Else Kröner-Exzellenzstipendium

Immunofluorescent picture of a two day old zebrafish heart

PRDM16 - ein wichtiger Transkriptionsfaktor für die Entstehung einer Kardiomyopathie Kurzbeschreibung des Projekts in einfachen, für die breite Öffentlichkeit verständlichen Worten

Institution: Department for Congenital Heart Disease and Pediatric Cardiology, UKSH. Kiel
Applicant: Dr. med. Anne-Karin Kahlert
EKFS funding line: first application

DNA Fäden im Reagenzglas. Neben der Abfolge der DNA Bausteine (Basen) spielen chemische Veränderungen der DNA Stränge eine wichtige Rolle, wie aktuell erforscht wird.

Molekulare Präzisionsmedizin bei Dilatativer Kardiomyopathie

Institution: Universitätsklinikum Heidelberg
Hauptantragsteller: Benjamin Meder
EKFS-Förderlinie: Else Kröner-Exzellenzstipendium

Pathological effects during cardiac aging and exercise-induced protective effects influence similar processes in the heart.

The role of cardiac CITED4 in age-dependent myocardial remodeling

Institution: Department of Cardiology, Angiology, Pulmonology, Center for Internal Medicine, University Hospital Heidelberg
Appliccant: Dr. med. Carolin Lerchenmüller
EKFS funding line: first application

Therefore, the aim of the present study was to assess the effect of empagliflozin on myocardial function in the human and murine myocardium and to identify the underlying mechanisms of action (together with PD Dr. Streckfuß-Bömeke).

Pleiotropic effects of Empagliflozin in human and mouse myocardium

Institution: Universitätsklinikum Regensburg, Universitätsmedizin Goettingen (UMG) Herzzentrum
Applicants: Prof. Dr. Samuel Tobias Sossalla, PD Dr. Katrin Streckfuß-Bömeke
EKFS funding line: key project

(a)	Arbeitsgruppe vor Ihren Postern auf dem Sleep and Breathing Kongress in Marseille, Frankreich

Pathophysiology of central sleep related breathing disorders and their mask based therapies in patients with chronic heart failure

Institution: Department of Neurology with Institute for Translational Neurology, University of Muenster
Applicant: Jens Spiesshoefer, MD
EKFS funding line: first application

Spontane pro-arrhythmische Kalziumfreisetzung in einer atrialen Herzmuskelzelle. Die neuartige Substanz „SEA“ verzögert das Einsetzen der Zelldepolarisation und wirkt damit zellulär antiarrhythmisch.

In-vivo and in-vitro atrial dysfunction in heart failure with preserved ejection fraction

Institution: Charité Campus Virchow Klinikum
Applicant: Felix Hohendanner
EKFS funding line: first application

Project leader PD Dr. Arash Haghikia (middle) and his team discuss results during lab meeting.    Left to rigth: Andrzei Jasina, Johann Rößler, Friederike Zimmermann, PD Dr. Arash Haghikia, Paul Schumann, Philipp Heinze, Vasana Nageswaran.

Effects of gut microbiota related metabolites on endothelial repair mechanisms and vascular remodeling

Institution: Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Dept. of Cardiology
Applicant: PD Dr. med. Arash Haghikia
EKFS funding line: first application

This research project investigates the function of a protein naturally produced in the body. This protein may be able to protect the arteries from calcification.

Identification of a novel inhibitor of vascular calcification

Institution: Charite Berlin
Applicant: Jakob Voelkl
EKFS funding line: first application